Delivery Order SPE2DB20D1051-SPE2DB25FD7UV

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Losartan Potassium 25 mg tablets. The contract has a firm-fixed price of $3,040.36 and a completion date of May 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan Potassium 25 mg tablets in 1,000-count containers. The contract has a ceiling value of $1,198.26 and a period of performance through May 5, 2025. This award is not set aside and is a firm-fixed-price contract type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $1,501.44 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,557,881,068 units of Losartan Potassium 50 mg tablets, with a completion date of July 25, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Losartan Potassium 50 mg tablets. The contract has a ceiling value of $1,187.88 and a performance period through May 2, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Losartan Potassium 100 mg tablets. The contract, valued at $1,760.48, has a firm fixed price and an ultimate completion date of January 24, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,198.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 50 mg Losartan Potassium tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,081,045 units of Losartan Potassium 100 mg tablets in 1,000-count bottles, with a ceiling value of $9,482.89. The contract is a Firm Fixed Price delivery order with a completion date of December 13, 2023. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,900.11 fixed-price contract is for the supply of Losartan Potassium 100 mg tablets to DLA. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 1,000 units of the medication Losartan Potassium 25 mg tablets, with a total ceiling value of $4,511.82. The contract is a firm fixed-price, non-set-aside award with a performance period extending through May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,567.77, is for the procurement of 4,564,885,548 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of June 13, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD7UV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Losartan Potassium 25 mg tablets. The contract has a firm fixed price of $1,011.51 and a completion date of April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set-aside and allows for the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/22/25, 9:49 AM